Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals Cash on Hand 2010-2025 | REGN

Regeneron Pharmaceuticals cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Regeneron Pharmaceuticals cash on hand for the quarter ending March 31, 2025 was $8.349B, a 20.63% decline year-over-year.
  • Regeneron Pharmaceuticals cash on hand for 2024 was $9.013B, a 16.9% decline from 2023.
  • Regeneron Pharmaceuticals cash on hand for 2023 was $10.845B, a 40.07% increase from 2022.
  • Regeneron Pharmaceuticals cash on hand for 2022 was $7.742B, a 35.96% increase from 2021.
  
Regeneron Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2024 $9,013
2023 $10,845
2022 $7,742
2021 $5,695
2020 $3,587
2019 $3,214
2018 $2,810
2017 $1,410
2016 $1,039
2015 $1,045
2014 $900
2013 $694
2012 $308
2011 $527
2010 $249
2009 $341
Regeneron Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $8,349
2024-12-31 $9,013
2024-09-30 $9,797
2024-06-30 $9,809
2024-03-31 $10,520
2023-12-31 $10,845
2023-09-30 $9,914
2023-06-30 $8,928
2023-03-31 $8,960
2022-12-31 $7,742
2022-09-30 $7,022
2022-06-30 $7,566
2022-03-31 $7,051
2021-12-31 $5,695
2021-09-30 $5,788
2021-06-30 $3,911
2021-03-31 $3,504
2020-12-31 $3,587
2020-09-30 $3,026
2020-06-30 $3,144
2020-03-31 $4,003
2019-12-31 $3,214
2019-09-30 $2,878
2019-06-30 $2,670
2019-03-31 $3,232
2018-12-31 $2,810
2018-09-30 $2,192
2018-06-30 $1,684
2018-03-31 $1,625
2017-12-31 $1,410
2017-09-30 $1,379
2017-06-30 $1,268
2017-03-31 $1,307
2016-12-31 $1,039
2016-09-30 $1,408
2016-06-30 $1,045
2016-03-31 $849
2015-12-31 $1,045
2015-09-30 $896
2015-06-30 $604
2015-03-31 $742
2014-12-31 $900
2014-09-30 $1,042
2014-06-30 $817
2014-03-31 $648
2013-12-31 $694
2013-09-30 $445
2013-06-30 $538
2013-03-31 $308
2012-12-31 $308
2012-09-30 $263
2012-06-30 $301
2012-03-31 $432
2011-12-31 $527
2011-09-30 $245
2011-06-30 $310
2011-03-31 $226
2010-12-31 $249
2010-09-30 $479
2010-06-30 $306
2010-03-31 $304
2009-12-31 $341
2009-09-30 $380
2009-06-30 $392
2009-03-31 $416
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $65.278B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $216.095B 16.13
Amgen (AMGN) United States $145.901B 13.07
Gilead Sciences (GILD) United States $133.996B 13.92
Vertex Pharmaceuticals (VRTX) United States $111.789B 0.00
Bristol Myers Squibb (BMY) United States $95.649B 6.40
GSK (GSK) United Kingdom $79.517B 9.45
CSL (CSLLY) Australia $75.634B 0.00
Alnylam Pharmaceuticals (ALNY) United States $38.149B 0.00
Argenex SE (ARGX) Netherlands $35.717B 97.49
BioNTech SE (BNTX) Germany $23.821B 0.00
BeiGene (ONC) Cayman Islands $23.424B 0.00
Royalty Pharma (RPRX) United States $18.925B 7.80
Biogen (BIIB) United States $18.583B 8.02
Genmab (GNMSF) Denmark $13.767B 14.08
Genmab (GMAB) Denmark $13.158B 14.76
Illumina (ILMN) United States $12.564B 23.83
Incyte (INCY) United States $12.539B 95.26
Insmed (INSM) United States $12.025B 0.00
Exelixis (EXEL) United States $11.923B 20.24
BioMarin Pharmaceutical (BMRN) United States $11.215B 18.22
Swedish Orphan Biovitrum (BIOVF) Sweden $10.858B 27.73
Exact Sciences (EXAS) United States $10.732B 0.00
Moderna (MRNA) United States $9.978B 0.00
Ascendis Pharma (ASND) Denmark $9.639B 0.00
QIAGEN (QGEN) Netherlands $9.407B 18.30
Roivant Sciences (ROIV) United Kingdom $7.785B 0.00
Bio-Techne Corp (TECH) United States $7.315B 27.29
Revolution Medicines (RVMD) United States $7.216B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Repligen (RGEN) United States $6.754B 75.60
Jazz Pharmaceuticals (JAZZ) Ireland $6.673B 6.43
Halozyme Therapeutics (HALO) United States $6.645B 12.72
Blueprint Medicines (BPMC) United States $6.556B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.307B 0.00
Telix Pharmaceuticals (TLX) Australia $5.630B 0.00
TG Therapeutics (TGTX) United States $5.429B 142.50
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $5.400B 0.00
Nuvalent (NUVL) United States $5.274B 0.00
Axsome Therapeutics (AXSM) United States $5.207B 0.00
Legend Biotech (LEGN) United States $5.206B 0.00
Alkermes (ALKS) Ireland $5.034B 13.51
ADMA Biologics Inc (ADMA) United States $4.803B 35.93
Guardant Health (GH) United States $4.595B 0.00
Zealand Pharma (ZLDPF) Denmark $4.504B 0.00
Vaxcyte (PCVX) United States $4.382B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.971B 0.00
Sarepta Therapeutics (SRPT) United States $3.936B 0.00
Akero Therapeutics (AKRO) United States $3.854B 0.00
Cytokinetics (CYTK) United States $3.739B 0.00
Avidity Biosciences (RNA) United States $3.690B 0.00
PTC Therapeutics (PTCT) United States $3.662B 6.37
Krystal Biotech (KRYS) United States $3.661B 28.21
ACADIA Pharmaceuticals (ACAD) United States $3.657B 32.13
Arcellx (ACLX) United States $3.612B 0.00
Zai Lab (ZLAB) China $3.596B 0.00
SpringWorks Therapeutics (SWTX) United States $3.482B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.348B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.195B 0.00
Alvotech (ALVO) Luxembourg $3.063B 17.52
Viking Therapeutics (VKTX) United States $3.060B 0.00
Metsera (MTSR) United States $3.013B 0.00
Merus (MRUS) Netherlands $2.991B 0.00
Scholar Rock Holding (SRRK) United States $2.917B 0.00
Protagonist Therapeutics (PTGX) United States $2.840B 61.09
MoonLake Immunotherapeutics (MLTX) Switzerland $2.467B 0.00
Immunovant (IMVT) United States $2.448B 0.00
ImmunityBio (IBRX) United States $2.339B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.337B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.305B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.195B 0.00
Apellis Pharmaceuticals (APLS) United States $2.189B 0.00
Ascentage Pharma Group - (AAPG) China $2.187B 0.00
Belite Bio (BLTE) United States $2.142B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.114B 0.00
Vericel (VCEL) United States $2.068B 1369.00
Bavarian Nordic (BVNRY) Denmark $2.042B 10.79
CG Oncology (CGON) United States $1.999B 0.00
Denali Therapeutics (DNLI) United States $1.989B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.981B 13.17
NovoCure (NVCR) Jersey $1.979B 0.00
Ligand Pharmaceuticals (LGND) United States $1.977B 0.00
Kymera Therapeutics (KYMR) United States $1.962B 0.00
Amicus Therapeutics (FOLD) United States $1.952B 211.33
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.906B 0.00
Apogee Therapeutics (APGE) United States $1.850B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.815B 0.00
Certara (CERT) United States $1.812B 33.85
Agios Pharmaceuticals (AGIO) United States $1.744B 0.00
Beam Therapeutics (BEAM) United States $1.732B 0.00
Twist Bioscience (TWST) United States $1.706B 0.00
Disc Medicine (IRON) United States $1.693B 0.00
IDEAYA Biosciences (IDYA) United States $1.677B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.640B 0.00
Biohaven (BHVN) United States $1.603B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.585B 0.00
Edgewise Therapeutics (EWTX) United States $1.535B 0.00
Travere Therapeutics (TVTX) United States $1.474B 0.00
Janux Therapeutics (JANX) United States $1.466B 0.00
Mesoblast (MESO) Australia $1.439B 0.00
Liquidia Technologies (LQDA) United States $1.424B 0.00
89BIO (ETNB) United States $1.403B 0.00
Structure Therapeutics (GPCR) United States $1.385B 0.00
Adaptive Biotechnologies (ADPT) United States $1.381B 0.00
GRAIL (GRAL) United States $1.348B 0.00
Celldex Therapeutics (CLDX) United States $1.324B 0.00
Vera Therapeutics (VERA) United States $1.300B 0.00
ANI Pharmaceuticals (ANIP) United States $1.280B 13.19
MannKind (MNKD) United States $1.267B 26.06
Pacira BioSciences (PCRX) United States $1.210B 11.52
BGM Group (BGM) China $1.201B 0.00
Dynavax Technologies (DVAX) United States $1.189B 70.71
Novavax (NVAX) United States $1.152B 2.68
Anbio Biotechnology (NNNN) Germany $1.122B 0.00
Viridian Therapeutics (VRDN) United States $1.115B 0.00
Mineralys Therapeutics (MLYS) United States $1.086B 0.00
MiMedx (MDXG) United States $1.019B 24.64
Gyre Therapeutics (GYRE) United States $0.972B 259.25
Intellia Therapeutics (NTLA) United States $0.953B 0.00
NeoGenomics (NEO) United States $0.952B 0.00
WAVE Life Sciences (WVE) Singapore $0.931B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.916B 0.00
Arcus Biosciences (RCUS) United States $0.912B 0.00
Spyre Therapeutics (SYRE) United States $0.891B 0.00
CureVac (CVAC) Germany $0.875B 4.24
Pharvaris (PHVS) Netherlands $0.858B 0.00
Geron (GERN) United States $0.853B 0.00
UniQure (QURE) Netherlands $0.849B 0.00
CorMedix Inc (CRMD) United States $0.834B 55.86
Zymeworks (ZYME) United States $0.831B 0.00
Oculis Holding AG (OCS) Switzerland $0.801B 0.00
Niagen Bioscience (NAGE) United States $0.798B 112.56
Bicara Therapeutics (BCAX) United States $0.796B 0.00
LENZ Therapeutics (LENZ) United States $0.792B 0.00
Praxis Precision Medicines (PRAX) United States $0.768B 0.00
Nurix Therapeutics (NRIX) United States $0.746B 0.00
Pharming Group (PHAR) Netherlands $0.714B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.704B 0.00
ArriVent BioPharma (AVBP) United States $0.700B 0.00
Nuvation Bio (NUVB) United States $0.691B 0.00
Immunome (IMNM) United States $0.689B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Anavex Life Sciences (AVXL) United States $0.664B 0.00
Replimune (REPL) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.638B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Vir Biotechnology (VIR) United States $0.623B 0.00
Immatics (IMTX) Germany $0.622B 0.00
Trevi Therapeutics (TRVI) United States $0.617B 0.00
GH Research (GHRS) Ireland $0.613B 0.00
AnaptysBio (ANAB) United States $0.611B 0.00
Arbutus Biopharma (ABUS) United States $0.607B 0.00
Dianthus Therapeutics (DNTH) United States $0.603B 0.00
Sionna Therapeutics (SION) United States $0.596B 0.00
AbCellera Biologics (ABCL) Canada $0.594B 0.00
Iovance Biotherapeutics (IOVA) United States $0.586B 0.00
Keros Therapeutics (KROS) United States $0.570B 0.00
Cogent Biosciences (COGT) United States $0.567B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.557B 0.00
Eton Pharmaceuticals (ETON) United States $0.543B 0.00
Kura Oncology (KURA) United States $0.537B 0.00
Opthea (OPT) Australia $0.525B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.523B 0.00
Tyra Biosciences (TYRA) United States $0.518B 0.00
Stoke Therapeutics (STOK) United States $0.518B 12.00
REGENXBIO (RGNX) United States $0.484B 0.00
Upstream Bio (UPB) United States $0.480B 0.00
Cullinan Therapeutics (CGEM) United States $0.464B 0.00
Castle Biosciences (CSTL) United States $0.463B 31.41
Maze Therapeutics (MAZE) United States $0.461B 0.00
Zenas BioPharma (ZBIO) United States $0.458B 0.00
Arvinas (ARVN) United States $0.456B 0.00
Sana Biotechnology (SANA) United States $0.442B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.433B 0.00
PureTech Health (PRTC) United States $0.430B 0.00
MeiraGTx Holdings (MGTX) United States $0.426B 0.00
Sage Therapeutics (SAGE) United States $0.426B 0.00
Tectonic Therapeutic (TECX) United States $0.422B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.419B 0.00
Verastem (VSTM) United States $0.418B 0.00
Oric Pharmaceuticals (ORIC) United States $0.417B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
MBX Biosciences (MBX) United States $0.409B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.404B 0.00
Septerna (SEPN) United States $0.404B 0.00
Celcuity (CELC) United States $0.401B 0.00
Kamada (KMDA) Israel $0.393B 23.55
Autolus Therapeutics (AUTL) United Kingdom $0.391B 0.00
Precigen (PGEN) United States $0.390B 0.00
Northwest Biotherapeutics (NWBO) United States $0.389B 0.00
Fortrea Holdings (FTRE) United States $0.380B 10.50
Myriad Genetics (MYGN) United States $0.375B 0.00
Abivax SA (ABVX) France $0.369B 0.00
Prothena (PRTA) Ireland $0.367B 0.00
Rapport Therapeutics (RAPP) United States $0.366B 0.00
Humacyte (HUMA) United States $0.363B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.356B 0.00
Benitec Biopharma (BNTC) United States $0.350B 0.00
Checkpoint Therapeutics (CKPT) United States $0.350B 0.00
Emergent Biosolutions (EBS) United States $0.349B 0.00
Alpha Teknova (TKNO) United States $0.347B 0.00
Erasca (ERAS) United States $0.346B 0.00
Absci (ABSI) United States $0.344B 0.00
Olema Pharmaceuticals (OLMA) United States $0.343B 0.00
Fulcrum Therapeutics (FULC) United States $0.337B 0.00
ATyr Pharma (ATYR) United States $0.334B 0.00
Abeona Therapeutics (ABEO) United States $0.330B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.330B 0.00
Cidara Therapeutics (CDTX) United States $0.329B 0.00
ITeos Therapeutics (ITOS) United States $0.315B 0.00
Cytek Biosciences (CTKB) United States $0.314B 0.00
XOMA Royalty (XOMA) United States $0.301B 0.00
Aura Biosciences (AURA) United States $0.300B 0.00
Entrada Therapeutics (TRDA) United States $0.292B 9.49
Compass Therapeutics (CMPX) United States $0.285B 0.00
Prima BioMed (IMMP) Australia $0.283B 0.00
Candel Therapeutics (CADL) United States $0.274B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.272B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Terns Pharmaceuticals (TERN) United States $0.262B 0.00
Gossamer Bio (GOSS) United States $0.261B 0.00
DBV Technologies S.A (DBVT) France $0.256B 0.00
Inozyme Pharma (INZY) United States $0.255B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.255B 0.00
Palvella Therapeutics (PVLA) United States $0.254B 0.00
Neurogene (NGNE) United States $0.249B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.247B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.247B 50.12
Allogene Therapeutics (ALLO) United States $0.243B 0.00
Rezolute (RZLT) United States $0.243B 0.00
Ocugen (OCGN) United States $0.242B 0.00
Aardvark Therapeutics (AARD) United States $0.241B 0.00
Cartesian Therapeutics (RNAC) United States $0.241B 0.00
Atea Pharmaceuticals (AVIR) United States $0.240B 0.00
Lifecore Biomedical (LFCR) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.234B 0.00
Third Harmonic Bio (THRD) United States $0.234B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Adherex Technologies (FENC) United States $0.229B 0.00
Amarin (AMRN) Ireland $0.227B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Alumis (ALMS) United States $0.226B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.222B 0.00
Astria Therapeutics (ATXS) United States $0.221B 0.00
GENFIT S.A (GNFT) France $0.217B 0.00
Monopar Therapeutics (MNPR) United States $0.217B 0.00
Semper Paratus Acquisition (TVGN) United States $0.217B 0.00
Annexon (ANNX) United States $0.216B 0.00
Actuate Therapeutics (ACTU) United States $0.215B 0.00
Bright Minds Biosciences (DRUG) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Nuvectis Pharma (NVCT) United States $0.210B 0.00
Solid Biosciences (SLDB) United States $0.209B 0.00
EnGene Holdings (ENGN) Canada $0.206B 0.00
Tango Therapeutics (TNGX) United States $0.205B 0.00
Design Therapeutics (DSGN) United States $0.204B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
BioStem Technologies (BSEM) $0.196B 7.99
ADC Therapeutics SA (ADCT) Switzerland $0.195B 0.00
Codexis (CDXS) United States $0.194B 0.00
Cardiff Oncology (CRDF) United States $0.193B 0.00
Urogen Pharma (URGN) United States $0.192B 0.00
Inhibrx Biosciences (INBX) United States $0.191B 0.11
Eledon Pharmaceuticals (ELDN) United States $0.189B 0.00
CARGO Therapeutics (CRGX) United States $0.187B 0.00
Kodiak Sciences (KOD) United States $0.187B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.186B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.181B 0.00
DiaMedica Therapeutics (DMAC) United States $0.177B 0.00
ScPharmaceuticals (SCPH) United States $0.176B 0.00
Voyager Therapeutics (VYGR) United States $0.174B 0.00
INmune Bio (INMB) United States $0.171B 0.00
Galena Biopharma (SLS) United States $0.170B 0.00
Anika Therapeutics (ANIK) United States $0.168B 0.00
Puma Biotechnology (PBYI) United States $0.166B 4.35
Tiziana Life Sciences (TLSA) United Kingdom $0.166B 0.00
AC Immune (ACIU) Switzerland $0.166B 0.00
CytomX Therapeutics (CTMX) United States $0.164B 4.25
Inventiva S.A (IVA) France $0.163B 0.00
Molecular Partners AG (MOLN) Switzerland $0.159B 0.00
Alpha Cognition (ACOG) Canada $0.158B 0.00
Prime Medicine (PRME) United States $0.153B 0.00
TuHURA Biosciences (HURA) United States $0.145B 0.00
BioAge Labs (BIOA) United States $0.140B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.137B 0.00
Fate Therapeutics (FATE) United States $0.134B 0.00
Greenwich LifeSciences (GLSI) United States $0.130B 0.00
EXoZymes (EXOZ) United States $0.127B 0.00
Editas Medicine (EDIT) United States $0.126B 0.00
Alector (ALEC) United States $0.125B 0.00
Seer (SEER) United States $0.124B 0.00
Compugen (CGEN) Israel $0.124B 0.00
Neumora Therapeutics (NMRA) United States $0.122B 0.00
Nkarta (NKTX) United States $0.121B 0.00
Rapt Therapeutics (RAPT) United States $0.117B 0.00
Theratechnologies (THTX) Canada $0.117B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Black Diamond Therapeutics (BDTX) United States $0.115B 33.83
InflaRx (IFRX) Germany $0.113B 0.00
Ventyx Biosciences (VTYX) United States $0.109B 0.00
Vigil Neuroscience (VIGL) United States $0.108B 0.00
Instil Bio (TIL) United States $0.106B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.105B 0.00
Medicus Pharma (MDCX) United States $0.104B 0.00
Tvardi Therapeutics (TVRD) United States $0.102B 0.00
Agenus (AGEN) United States $0.100B 0.00
BioHarvest Sciences (BHST) Canada $0.100B 0.00
Contineum Therapeutics (CTNM) United States $0.100B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
Sagimet Biosciences (SGMT) United States $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.099B 0.00
C4 Therapeutics (CCCC) United States $0.097B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.096B 0.00
Kyverna Therapeutics (KYTX) United States $0.096B 0.00
HilleVax (HLVX) United States $0.095B 0.00
Coya Therapeutics (COYA) United States $0.095B 0.00
Caribou Biosciences (CRBU) United States $0.094B 0.00
Genelux (GNLX) United States $0.094B 0.00
Invivyd (IVVD) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
Coherus BioSciences (CHRS) United States $0.090B 0.00
Immunic (IMUX) United States $0.088B 0.00
XBiotech (XBIT) United States $0.088B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.087B 0.00
23andMe Holding (MEHCQ) United States $0.087B 0.00
Entera Bio (ENTX) Israel $0.087B 0.00
Elicio Therapeutics (ELTX) United States $0.086B 0.00
Cellectis S.A (CLLS) France $0.084B 0.00
Senti Biosciences (SNTI) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Climb Bio (CLYM) United States $0.082B 0.00
Pliant Therapeutics (PLRX) United States $0.082B 0.00
Genenta Science S.p.A (GNTA) Italy $0.081B 0.00
Adagene (ADAG) China $0.078B 0.00
Alto Neuroscience (ANRO) United States $0.077B 0.00
I-Mab (IMAB) United States $0.077B 0.00
TScan Therapeutics (TCRX) United States $0.075B 0.00
CervoMed (CRVO) United States $0.074B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
IO Biotech (IOBT) Denmark $0.073B 0.00
Inovio Pharmaceuticals (INO) United States $0.073B 0.00
Jasper Therapeutics (JSPR) United States $0.072B 0.00
PDS Biotechnology (PDSB) United States $0.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
Tenaya Therapeutics (TNYA) United States $0.072B 0.00
Elutia (ELUT) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.071B 0.00
IGM Biosciences (IGMS) United States $0.071B 0.00
Zura Bio (ZURA) United States $0.070B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
Exicure (XCUR) United States $0.070B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Skye Bioscience (SKYE) United States $0.068B 0.00
MediciNova (MNOV) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
Seres Therapeutics (MCRB) United States $0.067B 0.00
Adlai Nortye (ANL) Cayman Islands $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
Akoya Biosciences (AKYA) United States $0.065B 0.00
VTv Therapeutics (VTVT) United States $0.064B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.063B 0.00
Citius Oncology (CTOR) United States $0.063B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Adicet Bio (ACET) United States $0.058B 0.00
Repare Therapeutics (RPTX) Canada $0.057B 0.00
OKYO Pharma (OKYO) $0.056B 0.00
Ikena Oncology (IKNA) United States $0.056B 0.00
TELA Bio (TELA) United States $0.055B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
Biomea Fusion (BMEA) United States $0.054B 0.00
Applied Therapeutics (APLT) United States $0.054B 0.00
Immuneering (IMRX) United States $0.053B 0.00
Precision BioSciences (DTIL) United States $0.052B 0.00
Shattuck Labs (STTK) United States $0.051B 0.00
Fortress Biotech (FBIO) United States $0.050B 0.00
Celularity (CELU) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Artiva Biotherapeutics (ARTV) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
Whitehawk Therapeutics (WHWK) United States $0.048B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
PepGen (PEPG) United States $0.047B 0.00
Quince Therapeutics (QNCX) United States $0.047B 0.00
Forte Biosciences (FBRX) United States $0.047B 0.00
Opus Genetics (IRD) United States $0.046B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.046B 0.00
Cue Biopharma (CUE) United States $0.045B 0.00
Connect Biopharma Holdings (CNTB) United States $0.045B 0.00
RenovoRx (RNXT) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
Xilio Therapeutics (XLO) United States $0.043B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Atara Biotherapeutics (ATRA) United States $0.041B 0.00
Kronos Bio (KRON) United States $0.041B 0.00
Rani Therapeutics Holdings (RANI) United States $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.040B 0.00
Annovis Bio (ANVS) United States $0.039B 0.00
Spero Therapeutics (SPRO) United States $0.038B 0.00
Boundless Bio (BOLD) United States $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Alterity Therapeutics - (ATHE) Australia $0.036B 0.00
Pluri (PLUR) Israel $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.035B 0.00
FibroBiologics (FBLG) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.034B 0.00
Aligos Therapeutics (ALGS) United States $0.034B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.033B 0.00
Quantum Biopharma (QNTM) Canada $0.033B 0.00
Scilex Holding (SCLX) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.031B 0.00
Dyadic (DYAI) United States $0.031B 0.00
Cadrenal Therapeutics (CVKD) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
OnKure Therapeutics (OKUR) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
Advanced Biomed (ADVB) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
CalciMedica (CALC) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.024B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.023B 0.00
Vor Biopharma (VOR) $0.023B 0.00
Clene (CLNN) United States $0.022B 0.00
BioAtla (BCAB) United States $0.022B 0.00
ALX Oncology Holdings (ALXO) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Ovid Therapeutics (OVID) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
ABVC BioPharma (ABVC) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Elevation Oncology (ELEV) United States $0.019B 0.00
Passage Bio (PASG) United States $0.019B 0.00
HOOKIPA Pharma (HOOK) United States $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
X4 Pharmaceuticals (XFOR) United States $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Kalaris Therapeutics (KLRS) United States $0.015B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
NextCure (NXTC) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Moleculin Biotech (MBRX) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
HCW Biologics (HCWB) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
IN8bio (INAB) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.011B 0.00
Athira Pharma (ATHA) United States $0.010B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Portage Biotech (PRTG) $0.008B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
MetaVia (MTVA) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Imunon (IMNN) United States $0.007B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
BioAffinity Technologies (BIAF) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Eyenovia (EYEN) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Novogen (KZIA) Australia $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Evaxion - (EVAX) Denmark $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Polyrizon (PLRZ) Israel $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00